European nursing home operator DomusVi has acquired two facilities in Chile through its subsidiary Acalis as part of a rapid expansion strategy across the region. This is the group's second acquisition in Latin America, as growth has otherwise been focused on greenfield. We speak to the CEO of Acalis Latam about the group's regional strategy.
Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis.
Panellists on the LatAm panel at HBI 2019 see good opportunities in the region thanks to booming demand, particularly as demographics shift from rural to urban bases, and with the growth of the chronic and elderly care markets. Increasing use of digital health tools and better data, plus the growth of the consumer market are also seen as positive factors for the market.
Orpea, Europe's second-largest nursing home operator by revenue, has made big strides in Latin America, with acquisitions in Chile, Brazil and Uruguay in 2018. We speak to a market expert about its expansion, with a focus on Brazil, and its full-year results published this week.
DomusVi, Europe's third-largest nursing home operator by revenue with a big presence in Spain, has acquired a minority stake in Latin American group Acalis. We speak to Acalis' CEO and a spokesperson for DomusVi about the deal.
The sale of Bridgepoint-owned international dialysis giant Diaverum is likley being delayed until the future of its lucrative Saudi contract is determined, as potential suitors adopt a wait and see approach, Healthcare Europa hears.